| CTRI Number |
CTRI/2024/09/074296 [Registered on: 24/09/2024] Trial Registered Prospectively |
| Last Modified On: |
23/09/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Other (Specify) [UTTARBASTI AND MATRA BASTI ALONG WITH ORAL MEDICINE] |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Ayurvedic management of Mootraghata ( benign prostate hyperplasia ) treated with Uttar Basti and oral medication to give relief from the Mootraghata ( benign prostate hyperplasia ). |
|
Scientific Title of Study
|
Comparative clinical effect of Varunadhya Taila Uttar Basti and Matra Basti along With Kanchanara Guggulu orally in the management of Mootraghata wsr benign prostatic hyperplasia - an open labelled randomized clinical study. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Keyur Rajeshbhai Chudasama |
| Designation |
Second Year Pg Scholar |
| Affiliation |
Shree Swaminarayan Ayurvedic Collage |
| Address |
3rd Floor, Post Graduation Department Of Shalya Tantra, Shree Swaminarayan Ayurvedic Collage, Ahmedabad- Mehsana Highway, At p.o. Saij, Kalol, Gandhinagar. Gujarat
Gandhinagar GUJARAT 382721 India |
| Phone |
9033359321 |
| Fax |
|
| Email |
keyur1941@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Anita Patel |
| Designation |
Professor |
| Affiliation |
Shree Swaminarayan Ayurvedic Collage |
| Address |
3rd Floor, Post Graduation Department Of Shalya Tantra, Shree Swaminarayan Ayurvedic Collage, Ahmedabad- Mehsana Highway, At p.o. Saij, Kalol, Gandhinagar. Gujarat
Gandhinagar GUJARAT 382721 India |
| Phone |
9176945090 |
| Fax |
|
| Email |
dranitasudha@swaminarayanuniversity.ac.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Neeraj Kumar |
| Designation |
Professor |
| Affiliation |
Shree Swaminarayan Ayurvedic Collage |
| Address |
3rd Floor, Post Graduation Department Of Shalya Tantra, Shree Swaminarayan Ayurvedic Collage, Ahmedabad- Mehsana Highway, At p.o. Saij, Kalol, Gandhinagar. Gujarat
Gandhinagar GUJARAT 382721 India |
| Phone |
7231053235 |
| Fax |
|
| Email |
doctorneerajsharma@gmail.com |
|
|
Source of Monetary or Material Support
|
| Shree Swaminarayan Ayurvedic College, Ahmedabad-Mehsana Highway, At.& Po. Saij,
Ta.Kalol, Dist. Gandhinagar-392725 |
|
|
Primary Sponsor
|
| Name |
Premswarup Swami Ayurvedic Multi Speciality Hospital Kalol |
| Address |
Shree Swaminarayan Ayurvedic College Premswarupswami Ayurvedic
multispeciality Hospital Ahmedabad-Mehsana Highway At and Po.Saji
Ta.Kalol Dist.Gandhinagar-382725 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Keyur Rajeshbhai Chudasama |
Premswarup Swami Ayurvedic Multi Speciality Hospital |
OPD 006 Department
of Shalya tantra,
Premswarup Swami
Ayurvedic
Multispeciallity Hospital,
Ahmedabad-Mehsana
highway At.& Po.
Saij,Ta Kalol,Dist.
Gandhingar-382725
Gandhinagar
GUJARAT Gandhinagar GUJARAT |
9033359321
keyur1941@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee Shree Swaminarayan Ayurvedic Collage And Hospital, Kalol. |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N401||Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: MUTRAGHATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | uttara-bastiH, उतà¥à¤¤à¤°-बसà¥à¤¤à¤¿à¤ƒ | (Procedure Reference: Sushruta Samhita. Chikitsa Sthana, Anuvasnotarbasti Chikitsa Adhyay, Procedure details: PROCEDURE OF UTTAR BASTI
PURVA KARMA:
Vitals (TPR, BP, and SpO2) of the patient will be taken.
Informed written consent will be taken.
An information sheet will be provided to all patients at the time of registration.
All the basti material, i.e., Varunadhya Taila, 20 ml and 2.5 ml syringes, feeding tubes no. 8 or 10 (as per requirement), betadine solution, gauze piece, Xylocaine jelly 2%, sponge holding forceps, and sterile cut sheet, will be kept ready on a tray.
PRADHAN KARMA:
The patient will be taken into a supine position on the OT table.
Under all aseptic precautions, local part preparation with Abhyanga and Swedana will be done.
Hold the penile circumferential area and insert xylocaine jelly with a 2.5-ml syringe.
Then, with the help of a 20-ml disposable syringe and feeding tube (size will be as per requirement), Varunadhya Taila will be slowly inserted through the urethra.
PASHCHAAT KARMA:
For holding the drug in situ, hold the penile area until the instilled tail doesn’t flow back from the urethra.
Cleaning of the penile area will be done.
After taking vitals again, the patient will be shifted to the ward for observation for 30 minutes. ) (1) Medicine Name: Varunadhya Taila , Reference: Bhaisajya Ratanavali, mutrakruchhchachikitsa, Route: Urethral, Dosage Form: Taila, Dose: 20(ml), Frequency: od, Duration: 14 Days | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Kanchanara guggulu, Reference: sarngadhara-samhita madhyama khanda, adhyay no. 7, vatakakalpana slok no. 94-100, Route: Oral, Dosage Form: Guggulu , Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -Luke warm water ), Additional Information: - | | 3 | Intervention Arm | Procedure | - | mAtrAbastiH, मातà¥à¤°à¤¾à¤¬à¤¸à¥à¤¤à¤¿à¤ƒ | (Procedure Reference: Sushruta Samhita. Chikitsa Sthana, Anuvasnotarbasti Chikitsa Adhyay, Procedure details: PROCEDURE OF MATRA BASTI
PURVA KARMA: Vitals (TPR, BP, & SpO2) of the patient will be taken. Informed written consent will be taken. An information sheet will be provided to all patients at the time of registration. All the Basti materials are ready on the tray, i.e., Varunadhya Taila, 60-ml syringe, red rubber catheter, betadine solution, gauze piece, and transpore tape.
PRADHAN KARMA: The patient will be taken in a left-lateral position. Locally, abhyanga and swedana will be done, and then, with the help of a syringe, 60 ml of Varunadhya Taila will be slowly instilled in the rectum with the help of a red rubber catheter.
PASHCHAAT KARMA: Rest for some time will be advised in the same position. After taking vitals again, the patient will be shifted to the ward for observation for 30 minutes )) (1) Medicine Name: Varunadhya Taila, Reference: Bhaisajya Ratanavali,adhyay no. 34 mutrakruchhchachikitsa slok no. 68, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 14 Days |
|
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Male |
| Details |
1.The patients having three or more signs from the diagnostic criteria (Benign Prostatic Hyperplasia).
2. blood pressure between 80 and 60 mmHg to 140 and 90 mmHg;
3. RBS below 140 mg/dl
4. As per the USG study, retention of urine with residual urine less than 200 ml.
5. Prostate size less than 200 cc.
6. Uttarbasti-arha. |
|
| ExclusionCriteria |
| Details |
1. Patients less than 40 years and more than 70 years
2. Patients with malignancy, congenital deformities of the urogenital tract, or any abdominal-pelvic pathology other than BPH
3. Systemic diseases like chronic renal failure CRF, uncontrolled hypertension BP is more than 150 by 90 of mmHg, diabetes mellitus RBS greater than 150 mg by dl,
4. Patients with hematuria and urolithiasis have localized infections.
5. Patients with chief complaints of tuberculosis, paralysis, or Parkinsonism will be excluded.
6. Known cases of cardiac diseases History Of MI, IHD.
7. Patient is HIV, HBsAg, HCV, or VDRL positive.
8. Chronic retention of urine with residual urine of more than 200 ml
9. Prostate size more than 200 cc.
10. Complications such as hydroureter, hydronephrosis, stone formation, recurrent infection, bladder changes, Stricture urethra, Prostate carcinoma, idiopathic bladder neck obstruction, bladder neck hypertrophy, and haematuria
11.bastianarha |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Relief in the clinical symptoms of Mootraghata (Benign Prostatic Hyperplasia). |
21 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Decrease In Size Of Prostate |
21 DAYS |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
09/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="2" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
In mutravaha strotas vikaras,
the line of treatment is basti chikitsa. So to check which kind of basti
chikitsa shows better result, I took this condition as an opportunity. After completing
this study, the results will be helpful in future to make standard treatment
protocol for BPH.
In this study, I will give
uttarbasti and matrabasti in to two different groups and also give kanchanara
guggulu with luke warm water. The expected outcome of this study is to get
symptomatic relief from the BPH. After completion of the study the conclusion
will be made. |